Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
![]() |
Fig.6.F
Chen M et al. (2020) |
Xla Wt + tmem79 MO
NF16 (in situ hybridization) |
|
|||||
![]() |
Fig. 1 l
Ma P et al. (2017) |
Xla Wt + zc4h2 MO
NF18 (Other Detection Assay) |
||||||
![]() |
Fig. 2
Ma P et al. (2017) |
Xla Wt + zc4h2 MO
NF18 (Other Detection Assay) |
|
|||||
![]() |
fig.5.b
Wang C et al. (2015) |
Xla Wt + ets1
NF17 (in situ hybridization) |
|
|||||
![]() |
fig.7.i
Wang C et al. (2015) |
Xla Wt + ets1del_1-450
NF17 (in situ hybridization) |
|
|||||
![]() |
Fig.7.I
Wang C et al. (2015) |
Xla Wt + ets1del_1-450
NF17 (in situ hybridization) |
|
|||||
![]() |
fig.7.j
Wang C et al. (2015) |
Xla Wt + ets1del_1-906
NF17 (in situ hybridization) |
|
|||||
![]() |
Fig.7.J
Wang C et al. (2015) |
Xla Wt + ets1del_1-906
NF17 (in situ hybridization) |
|
|||||
![]() |
fig.6.c,d
Vega-López GA et al. (2015) |
Xla Wt + hes1-GR + DEX
NF16 (in situ hybridization) |
|
|||||
![]() |
fig.5.j
Vega-López GA et al. (2015) |
Xla Wt + hes4 MO
NF16 (in situ hybridization) |
|